• Debt to Equity ratio2 stood at 0.80 times as of 30 September 2019, decreased from 0.94 times as at end of 2018 Changes in accounting policy and reclassification in 3Q19, during the 3-month and 9-month
its subsidiaries as details below: (Unit: Baht millions) For the period of three months Consolidated financial statement ended 30th June Apr 2018 - June 2018 Apr 2017 - June 2017 Change % Change Revenue
, Return on Equity ratio at 10.18 percent, Return on Total Assets ratio at 3.81 percent, Debt to Equity ratio at 1.68 times and Interest Bearing Debt to Equity ratio at 1.41 times. * The operational results
, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Consolidated For the Year Ended December 31 2019 2018 MB % MB % Total revenues 375.89 100.00 317.58 100.00
relation to import duty assessment. งบกาํไรขาดทุนเบ็ดเสร็จ Consolidated For the Year Ended December 31 2019 2018 MB % MB % Total revenues 375.89 100.00 317.58 100.00 Cost of sales (157.39) (41.87) (125.04
relation to import duty assessment. Consolidated For the Year Ended December 31 2019 2018 MB % MB % Total revenues 375.89 100.00 317.58 100.00 Cost of sales (157.39) (41.87) (125.04) (39.77) Selling expenses
Gross Margin 7.42% -2.09% Net Profit Margin -12.37% -14.39% Debt to Equity Ratio (Time) 8.96 5.88 Total Expenses The 3-month Operating Result as ended 30 June 2017 Construction Income In the 2nd quarter
: pato1@cscoms.com August 11, 2017 President The Stock Exchange of Thailand The consolidated financial statement of Pato Chemical Industry Plc. and its subsidiary for Q2 ended June 30, 2017 operational
Limited (“the Company”) would like to clarify the consolidated financial statements of the Company for the 2nd quarter of fiscal year 2017 ended as of June 30, 2017, which can be summarized as follows
81.0 million, or 72.0% yoy. Dusit Thani PCL Management Discussion and Analysis For the 2nd Quarter 2017 P a g e | 5 Financial Position The significant items in the consolidated statement of financial